2-Aminoisonicotinonitrile → N-(4-cyanopyridin-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
Reaktionsgleichung
F[C:2]1[CH:7]=[CH:6][N:5]=[C:4]([NH:8][C:9](=[O:25])[C:10]2[CH:15]=[CH:14][C:13]([B:16]3[O:20][C:19]([CH3:22])([CH3:21])[C:18]([CH3:24])([CH3:23])[O:17]3)=[CH:12][CH:11]=2)[CH:3]=1.[NH2:26][C:27]1C=C(C=CN=1)C#N>>[C:27]([C:2]1[CH:7]=[CH:6][N:5]=[C:4]([NH:8][C:9](=[O:25])[C:10]2[CH:15]=[CH:14][C:13]([B:16]3[O:20][C:19]([CH3:22])([CH3:21])[C:18]([CH3:24])([CH3:23])[O:17]3)=[CH:12][CH:11]=2)[CH:3]=1)#[N:26]Komponenten
3
Versuchsvorschrift
This compound was prepared, in an analogous manner as described in Intermediate 4, starting from 2-aminoisonicotinonitrile, to afford the title compound (1.3 g, 99%).
Aufarbeitung
- customThis compound was prepared, in an analogous manner
Quellen und Nachweise
- ORD-Eintrag
- ord-b2c09bf5e67744fe81138f0832298007
- Quelldatensatz
- uspto-grants-2016_03
- Patentnummer
- US09290504B2
Notizen zur Reaktion
Wird geladen…